REQUEST A DEMO
Total
USD $0.00
Search more companies

Swixx Biopharma Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Swixx Biopharma Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Swixx BioPharma is a commercialization platform in the pharmaceutical industry, with a focus on rare diseases, oncology/hematology, specialty care, and vaccines. The company operates through local partners in Kosovo and Moldova and has 100%-owned affiliates in multiple countries.

Headquarters
Arpad fejedelem utja 26-28.
Budapest; Budapest; Postal Code: 1023

Contact Details: Purchase the Swixx Biopharma Kft. report to view the information.

Website: http://www.swixxbiopharma.com

Basic Information
Total Employees:
Purchase the Swixx Biopharma Kft. report to view the information.
Outstanding Shares:
Purchase the Swixx Biopharma Kft. report to view the information.
Registered Capital:
Purchase the Swixx Biopharma Kft. report to view the information.
Financial Auditors:
Purchase the Swixx Biopharma Kft. report to view the information.
Incorporation Date:
February 08, 2017
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Swixx Biopharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
43.05%
Total operating revenue
42.68%
Operating profit (EBIT)
-6.08%
EBITDA
-14.6%
Net Profit (Loss) for the Period
47.79%
Total assets
30.92%
Total equity
44.87%
Operating Profit Margin (ROS)
-1.99%
Net Profit Margin
0.11%
Return on Equity (ROE)
0.61%
Quick Ratio
-0.32%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?